top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
For Some Cancers Are There Immunotherapy Hazards?
A report by French investigators has raised concern regarding the broad application of immunotherapy in lung cancer. Checkpoint...
Dr. Robert A. Nagourney, MD
Oct 25, 20183 min read
Cancer, Computers and Genes: A Bad Mix for Patients
Every day, we hear of another breakthrough using gene testing and DNA to identify a new target, new treatment, new combination or novel...
Dr. Robert A. Nagourney, MD
Aug 31, 20183 min read
High Cost of Cancer Care To 340B or Not To 340B, That Is The Question?
There are many reasons why medical care costs continue to spiral out of control. Some of these are systemic like an aging population,...
Dr. Robert A. Nagourney, MD
Jul 31, 20184 min read
The Right Treatment at the Right Time: Double-Hit Lymphoma
On February 5th, 2018 I was asked to consult on a 53-year-old patient who was admitted to the hospital with a one month’s history of low...
Dr. Robert A. Nagourney, MD
Jun 15, 20187 min read
Cancer Patients and the "Right To Try"
On May 30, 2018 the president signed HR 878, granting terminally ill patients the right to try experimental drugs. While there has been...
Dr. Robert A. Nagourney, MD
Jun 9, 20187 min read
Cancer Patients Want to Win, but is the Playing Field Level?
Anyone diagnosed with cancer knows the drill. After the initial shock, many go to the internet in pursuit of honest and reliable...
Dr. Robert A. Nagourney, MD
May 10, 20184 min read
Cancer Chemotherapy Costs Continue to Rise
The skyrocketing cost of cancer therapy has become a popular topic of discussion as a recent article in the Wall Street Journal made...
Dr. Robert A. Nagourney, MD
Apr 10, 20182 min read
Cancer Patients Need More Than "Me Too" Drugs
Cancer drug developments follow a rather predictable course. A new breakthrough is followed by a flurry of interest as the large...
Dr. Robert A. Nagourney, MD
Apr 4, 20183 min read
For Lung Cancer, We've Got the Answer, Now We're Waiting For the Question
As I finished a recent Thursday afternoon clinic, I received a call. The voice was familiar and I recognized it to belong to the husband...
Dr. Robert A. Nagourney, MD
Mar 28, 20183 min read
For Advanced Cancer Patients: The Clinical Trial Dilemma
Patients confronting advanced cancer are encouraged to participate in clinical trials. Clinical trials are employed to develop new drugs...
Dr. Robert A. Nagourney, MD
Mar 10, 20187 min read
In Advanced Breast Cancer, Sometimes the Patient Knows Best
She had been diagnosed in December 2012 with estrogen receptor positive breast cancer and received appropriate and aggressive therapy.
Dr. Robert A. Nagourney, MD
Feb 9, 20184 min read
Wisdom Imparted From A Cancer Patient To His Physician: Lessons Learned
The practice of medicine offers physicians the opportunity to meet people from many walks of life. In medical oncology, the relationships...
Dr. Robert A. Nagourney, MD
Jan 4, 20184 min read
Do Doctors Have Egg on Their Faces?
Few of us have escaped the medical community's admonition that eggs are a hazard to our health. Based on the cholesterol found in egg...
Dr. Robert A. Nagourney, MD
Dec 11, 20173 min read
Drug Resistant Acute Myeloid Leukemia Meets Its Match
Among the diseases that hematologist-oncologists regularly treat, acute myelogenous leukemia (AML) can be viewed as a qualified success....
Dr. Robert A. Nagourney, MD
Nov 21, 20174 min read
In Sarcoma, Does The Absence Of Mutations Mean There Is No Cancer?
I was recently approached by the father of a young patient with recurrent sarcoma. After several surgeries and multiple courses of...
Dr. Robert A. Nagourney, MD
Oct 26, 20173 min read
In Cancer Medicine, the Most Dangerous People Are Often the "Experts"
Many people may be aware of the controversies surrounding micro-nutrition, diet and lifestyle, vitamin supplementation and other...
Dr. Robert A. Nagourney, MD
Oct 12, 20174 min read
Choosing Therapy For Stage 4 Pancreatic Cancer: What Are The Criteria?
Pancreatic cancer afflicts 53,000 patients each year in the U.S. and has overtaken breast cancer as the third leading cause of cancer...
Dr. Robert A. Nagourney, MD
Sep 8, 20173 min read
Recurrent BRCA Positive Ovarian Cancer: An Unexpected Opportunity
For the over 22,000 women in the United States diagnosed each year with ovarian cancer outcomes have improved slowly, yet the majority of...
Dr. Robert A. Nagourney, MD
Aug 30, 20173 min read
Is 19 Years Old Too Young for Stage 4 Colon Cancer or Hospice?
COLORECTAL CANCER is among the most common malignancies in the US with 95,000 colon and 39,000 rectal cancer cases estimated to occur in...
Dr. Robert A. Nagourney, MD
Aug 2, 20174 min read
The Cost of Care for Stage 4 Colon Cancer: How Much is Too Much?
Among the most important topics of discussion at cancer meetings today is the cost of cancer care. Terms like “financial toxicity” are...
Dr. Robert A. Nagourney, MD
Jul 6, 20173 min read
bottom of page